Gain Therapeutics, Inc. (GANX) vs iBio, Inc. (IBIO)
Gain Therapeutics, Inc. and iBio, Inc. are both Biotechnology companies. Gain Therapeutics, Inc. and iBio, Inc. are of similar size ($80.3M and $77.3M). Gain Therapeutics, Inc. grew revenue faster over the last twelve months: 18.4% against −66.6%. Across the 14 metrics below, iBio, Inc. leads on 10 and Gain Therapeutics, Inc. on 4.
Valuation
Profitability
| Metric | GANX | IBIO | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 100.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (268.30%) | (65.70%) | (57.72%) |
| Return on assets | (159.22%) | (54.04%) | (49.22%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack